ARCHIVES

NCI Halts Routine P01 Site Visits Due to Travel Cut

This article is from The Cancer Letter archive.

Vol. 18 No. 06 | February 7, 1992

Download PDF Visit The Full Archive

Related Articles

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

September 17, 2010

Perifosine, Sorafenib Combination Well Tolerated in Several Lymphomas

December 28, 2012

Cancer Policy: New Cancer Board to Take A Year to Conduct First Study

April 18, 1997

HPV Can Affect Response To Radiation Therapies

September 28, 2012

NCI Awards 12 Grants For Planning of New Cancer Centers

March 27, 1992

Minorities Increasingly Involved In Research, Training Programs

December 5, 1986